{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:07:04Z","timestamp":1793135224852,"version":"4.5.0"},"reference-count":154,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jaci.2021.06.030","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T07:03:17Z","timestamp":1628492597000},"page":"964-983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A\u00a0Work Group Report of the AAAAI Allergic Skin Diseases Committee"],"prefix":"10.1016","volume":"148","author":[{"given":"Nives","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Pablo","family":"Abonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Dreskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne S.","family":"Happel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9sir\u00e9e","family":"Larenas-Linnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Nanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Wasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Wechsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.06.030_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fmed.2017.00261","article-title":"Eosinophilic gastrointestinal disorders pathology","volume":"4","author":"Collins","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2021.06.030_bib2","first-page":"1","article-title":"Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring","volume":"30","author":"Collins","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaci.2021.06.030_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.iac.2014.01.010","article-title":"Pathology of extramedullary mastocytosis","volume":"34","author":"Doyle","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2021.06.030_bib4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PAS.0000000000000190","article-title":"A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients","volume":"38","author":"Doyle","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib5","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1309\/AJCPSGQ71GJQQACL","article-title":"Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis","volume":"144","author":"Reichard","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2021.06.030_bib7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2003.014860","article-title":"Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge","volume":"57","author":"Horny","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000305552","article-title":"Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review","volume":"77","author":"Horny","year":"2010","journal-title":"Pathobiology"},{"key":"10.1016\/j.jaci.2021.06.030_bib9","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. 3rd ed. World Health Organization Classification of Tumours. Geneva (Switzerland): World Health Organization; 2001."},{"key":"10.1016\/j.jaci.2021.06.030_bib10","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib11","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.jaci.2021.06.030_bib12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2021.06.030_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0560.2006.00602.x","article-title":"Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis","volume":"34","author":"Sundram","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1165\/ajrcmb\/6.1.37","article-title":"Histochemical and immunohistochemical characteristics of mast cells in nasal polyps","volume":"6","author":"Kawabori","year":"1992","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaci.2021.06.030_bib15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000487538","article-title":"The staining of mast cells: a historical overview","volume":"176","author":"Ribatti","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jaci.2015.05.008","article-title":"Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis","volume":"137","author":"Alvarez-Twose","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib18","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1182\/blood-2015-03-637728","article-title":"Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis","volume":"126","author":"Blatt","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/modpathol.2010.224","article-title":"Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis","volume":"24","author":"Sotlar","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib20","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/his.12221","article-title":"CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis","volume":"63","author":"Morgado","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.jaci.2021.06.030_bib21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-16-2234","article-title":"Advances in the classification and treatment of mastocytosis: current status and outlook toward the future","volume":"77","author":"Valent","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaci.2021.06.030_bib22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/jcp.34.8.851","article-title":"Human intestinal mucosal mast cells: evaluation of fixation and staining techniques","volume":"34","author":"Strobel","year":"1981","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib23","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1600-0560.2009.01414.x","article-title":"Cutaneous mast cell counts\u2014what constitutes a \u201cnormal\u201d number?","volume":"37","author":"O'Neill","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.canlet.2009.01.039","article-title":"Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis","volume":"279","author":"Ribatti","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jaci.2021.06.030_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/jcp.2004.017210","article-title":"Mast cell distribution in normal adult skin","volume":"58","author":"Janssens","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/PAS.0b013e318078ce7a","article-title":"Immunoreactivity for CD25 in gastrointestinal mucosal mast\u00a0cells is specific for systemic mastocytosis","volume":"31","author":"Hahn","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2016.03.004","article-title":"Histologic analysis of eosinophils and mast cells of the gastrointestinal tract in healthy Canadian children","volume":"54","author":"Chernetsova","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2350\/10-07-0878-OA.1","article-title":"Normal quantity and distribution of mast cells and eosinophils in the pediatric colon","volume":"14","author":"Saad","year":"2011","journal-title":"Pediatr Dev Pathol"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2021.06.030_bib29","doi-asserted-by":"crossref","first-page":"AB182","DOI":"10.1016\/j.jaci.2009.12.713","article-title":"Number and distribution of mast cells in the pediatric gastrointestinal tract [abstr]","volume":"125","author":"Tison","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.06.030_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/gut.2006.100594","article-title":"Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum","volume":"56","author":"Guilarte","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2021.06.030_bib32","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","article-title":"Increased mast cells in the irritable bowel syndrome","volume":"12","author":"O'Sullivan","year":"2000","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jaci.2021.06.030_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/gut.16.11.861","article-title":"Mast cells and immunoglobulin E in inflammatory bowel disease","volume":"16","author":"Lloyd","year":"1975","journal-title":"Gut"},{"key":"10.1016\/j.jaci.2021.06.030_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF01296289","article-title":"Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis: a prospective controlled study","volume":"32","author":"Sarin","year":"1987","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaci.2021.06.030_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4103\/1319-3767.101128","article-title":"Analysis of colonic mucosa mast cell count in patients with chronic diarrhea","volume":"18","author":"Zare-Mirzaie","year":"2012","journal-title":"Saudi J Gastroenterol"},{"key":"10.1016\/j.jaci.2021.06.030_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0140-6736(82)91152-7","article-title":"Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma","volume":"2","author":"Filley","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2021.06.030_bib37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1056\/NEJM198508013130502","article-title":"Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis","volume":"313","author":"Leiferman","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.06.030_bib38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1136\/jcp.2005.031922","article-title":"Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy","volume":"59","author":"Mueller","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cgh.2009.03.022","article-title":"A novel histologic scoring system to evaluate mucosal biopsies from patients with eosinophilic esophagitis","volume":"7","author":"Protheroe","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaci.2021.06.030_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1465-9921-12-116","article-title":"Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury","volume":"12","author":"Willetts","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2021.06.030_bib41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1103005","article-title":"Eosinophil granule protein localization in eosinophilic endomyocardial disease","volume":"365","author":"Wright","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.06.030_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14055","article-title":"Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation","volume":"33","author":"Nelson","year":"2021","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jaci.2021.06.030_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/ijd.12330","article-title":"Provider-to-provider communication in dermatology and implications of missing clinical information in skin biopsy requisition forms: a systematic review","volume":"53","author":"Comfere","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2021.06.030_bib44","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib45","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jaci.2013.11.039","article-title":"Mendelian inheritance of elevated serum tryptase associated with atopy and connective tissue abnormalities","volume":"133","author":"Lyons","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib46","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2021.06.030_bib47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","article-title":"Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma and Immunology; and the European Academy of Allergology and Clinical Immunology","volume":"137","author":"Hartmann","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2017.10.002","article-title":"Barrier dysfunction in the skin allergy","volume":"67","author":"Egawa","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2021.06.030_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.forsciint.2016.04.025","article-title":"Postmortem detection of antibiotic-specific immunoglobulin E in the case of anaphylactic death","volume":"266","author":"Takahashi","year":"2016","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jaci.2021.06.030_bib50","series-title":"Kaposi Varicelliform Eruption","author":"Karray","year":"2020"},{"key":"10.1016\/j.jaci.2021.06.030_bib51","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.5858\/133.9.1490","article-title":"Grover disease (transient acantholytic dermatosis)","volume":"133","author":"Weaver","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaci.2021.06.030_bib52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.det.2016.07.005","article-title":"Dermatologic manifestations of monogenic autoinflammatory diseases","volume":"35","author":"Shwin","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2021.06.030_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1468-3083.2000.00021.x","article-title":"Prurigo nodularis of Hyde: an update","volume":"14","author":"Accioly-Filho","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2021.06.030_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13223-018-0316-z","article-title":"Melkersson-Rosenthal syndrome: a case report of a rare disease with overlapping features","volume":"15","author":"Cancian","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.det.2014.12.008","article-title":"Best way to perform a punch biopsy","volume":"33","author":"Dominguez-Cherit","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaci.2021.06.030_bib56","series-title":"Skin Biopsy","author":"Ramsey","year":"2020"},{"key":"10.1016\/j.jaci.2021.06.030_bib57","series-title":"Improving Diagnosis in Health Care","year":"2015"},{"key":"10.1016\/j.jaci.2021.06.030_bib58","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/DAD.0000000000000842","article-title":"Histomorphology and immunophenotype of eczematous skin lesions revisited-skin biopsies are not reliable in differentiating allergic contact dermatitis, irritant contact dermatitis, and atopic dermatitis","volume":"40","author":"Frings","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib59","first-page":"259","article-title":"Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immunology; Joint Council of Allergy, Asthma, and Immunology. Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib60","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/jcp.2005.027151","article-title":"My approach to superficial inflammatory dermatoses","volume":"58","author":"Alsaad","year":"2005","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaci.2016.06.049","article-title":"Chronic spontaneous urticaria: implications of subcutaneous inflammatory cell infiltration in an intractable clinical course","volume":"139","author":"Itoh","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib62","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: a histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2021.06.030_bib63","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-2133.2003.05090.x","article-title":"Pattern analysis of human cutaneous mast cell populations by total body surface mapping","volume":"148","author":"Weber","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2021.06.030_bib64","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1046\/j.1365-2222.1999.00678.x","article-title":"Grass pollen immunotherapy decreases the number of mast cells in the skin","volume":"29","author":"Durham","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2021.06.030_bib65","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.4081\/dr.2011.e12","article-title":"Telangiectasia macularis eruptiva perstans: more than skin deep","volume":"3","author":"Watkins","year":"2011","journal-title":"Dermatol Reports"},{"key":"10.1016\/j.jaci.2021.06.030_bib66","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/PAS.0b013e3180ca9a02","article-title":"CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis","volume":"32","author":"Hollmann","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-1-4939-1173-8_16","article-title":"Identification and immunophenotypic characterization of normal and pathological mast cells","volume":"1192","author":"Morgado","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jaci.2021.06.030_bib68","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.3314\/mmj.17.006","article-title":"Practical management of deep cutaneous fungal infections","volume":"58","author":"Sato","year":"2017","journal-title":"Med Mycol J"},{"key":"10.1016\/j.jaci.2021.06.030_bib69","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2559.2009.03443.x","article-title":"The histological assessment of cutaneous vasculitis","volume":"56","author":"Carlson","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.jaci.2021.06.030_bib70","series-title":"Approach to the patient with cutaneous blisters","author":"Hull","year":"2019"},{"key":"10.1016\/j.jaci.2021.06.030_bib71","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ad.2011.05.007","article-title":"Basic concepts in skin biopsy: part I","volume":"103","author":"Llamas-Velasco","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaci.2021.06.030_bib72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000349986","article-title":"KIT D816V mutation-positive cell fractions in lesional skin biopsies from adults with systemic mastocytosis","volume":"226","author":"Kristensen","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2021.06.030_bib73","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ajh.24876","article-title":"Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management","volume":"92","author":"Wilcox","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010302","article-title":"Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells","volume":"7","author":"Watanabe","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2021.06.030_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bjd.13683","article-title":"Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study","volume":"173","author":"Ortonne","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2021.06.030_bib76","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.iac.2015.05.005","article-title":"Eosinophilia in dermatologic disorders","volume":"35","author":"de Graauw","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2021.06.030_bib77","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12016-015-8485-8","article-title":"Eosinophilic skin diseases: a comprehensive review","volume":"50","author":"Long","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib78","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jaip.2018.06.002","article-title":"Eosinophil-related disease and the skin","volume":"6","author":"Leiferman","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.030_bib79","first-page":"31","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"6","author":"Choudhary","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaci.2021.06.030_bib80","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/ijms18061243","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system","volume":"18","author":"Cho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2021.06.030_bib81","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/his.13033","article-title":"Clinicopathological characteristics of systemic mastocytosis in the intestine","volume":"69","author":"Shih","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.jaci.2021.06.030_bib82","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE Conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.06.030_bib83","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1067\/mai.2001.119917","article-title":"Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response","volume":"108","author":"Straumann","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib84","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaci.2010.04.009","article-title":"Involvement of mast cells in eosinophilic esophagitis","volume":"126","author":"Abonia","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib85","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2010.08.050","article-title":"Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction","volume":"126","author":"Aceves","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib86","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1111\/all.13530","article-title":"Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis","volume":"73","author":"Tappata","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2021.06.030_bib87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.201002-0295OC","article-title":"Mast cell phenotype, location, and activation in severe asthma: data from the Severe Asthma Research Program","volume":"183","author":"Balzar","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2021.06.030_bib88","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3389\/fimmu.2018.02193","article-title":"An optimized protocol for the isolation and functional analysis of human lung mast cells","volume":"9","author":"Ravindran","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib89","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.3748\/wjg.14.7005","article-title":"Gastrointestinal manifestations of systemic mastocytosis","volume":"14","author":"Lee","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaci.2021.06.030_bib90","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.5858\/arpa.2013-0271-CR","article-title":"Systemic mastocytosis involving the gastrointestinal tract: case report and review","volume":"137","author":"Behdad","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaci.2021.06.030_bib91","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0016-5107(96)70019-6","article-title":"Endoscopic findings in systemic mastocytosis","volume":"44","author":"Scolapio","year":"1996","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jaci.2021.06.030_bib92","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mpdhp.2016.04.005","article-title":"Gastrointestinal manifestations of systemic mastocytosis","volume":"22","author":"Vajpeyi","year":"2016","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib93","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct\u00a0small intestine mast cell histologic changes in patients with hereditary alpha-tryptasemia and mast cell activation syndrome","volume":"45","author":"Hamilton","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib94","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13192","article-title":"Colonic immune cells in irritable bowel syndrome: a systematic review and meta-analysis [e-pub ahead of print]","volume":"30","author":"Bashashati","year":"2018","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.jaci.2021.06.030_bib95","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3748\/wjg.v17.i34.3948","article-title":"Severe chronic diarrhea and maculopapular rash: a case report","volume":"17","author":"Elvevi","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaci.2021.06.030_bib96","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/his.13653","article-title":"Eosinophilic oesophagitis: relevance of mast cell infiltration","volume":"73","author":"Strasser","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.jaci.2021.06.030_bib97","doi-asserted-by":"crossref","first-page":"362","DOI":"10.5858\/2006-130-362-MEIMMC","article-title":"Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea","volume":"130","author":"Jakate","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jaci.2021.06.030_bib98","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib99","doi-asserted-by":"crossref","first-page":"224","DOI":"10.14309\/ajg.0000000000000474","article-title":"Mast cell infiltration is associated with persistent symptoms and endoscopic abnormalities despite resolution of eosinophilia in pediatric eosinophilic esophagitis","volume":"115","author":"Bolton","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2021.06.030_bib100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1590\/s0004-2803.201700000-23","article-title":"Mast cells distinguish eosinophilic esophagitis in pediatric patients","volume":"54","author":"Lomazi","year":"2017","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.jaci.2021.06.030_bib101","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jaci.2015.03.004","article-title":"Pediatric Eosinophilic Esophagitis Symptom Scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease","volume":"135","author":"Martin","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib102","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2350\/11-05-0130.1","article-title":"Quantity and distribution of eosinophils in the gastrointestinal tract of children","volume":"9","author":"DeBrosse","year":"2006","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib103","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib104","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaci.2015.04.024","article-title":"Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis","volume":"136","author":"Carter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaci.2021.06.030_bib106","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1373\/clinchem.2006.068205","article-title":"Sensitive detection of KIT D816V in patients with mastocytosis","volume":"52","author":"Tan","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jaci.2021.06.030_bib107","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/ejh.12128","article-title":"Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis","volume":"91","author":"Kristensen","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib108","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/leu.2015.24","article-title":"KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis","volume":"29","author":"Arock","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2021.06.030_bib109","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib111","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood-2009-05-220145","article-title":"Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies","volume":"114","author":"Pardanani","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib112","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/blood-2009-10-249979","article-title":"WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults","volume":"115","author":"Pardanani","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib113","doi-asserted-by":"crossref","first-page":"e4934","DOI":"10.1097\/MD.0000000000004934","article-title":"Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: a case report","volume":"95","author":"Huang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2021.06.030_bib114","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaci.2020.11.017","article-title":"Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology","volume":"147","author":"Giannetti","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jaci.2012.02.019","article-title":"Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes","volume":"130","author":"Valent","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib116","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.jaip.2018.04.030","article-title":"Consultation for elevated blood eosinophils: clinical presentations, high value diagnostic tests, and treatment options","volume":"6","author":"Khoury","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2021.06.030_bib117","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1751-553X.2008.01100.x","article-title":"ICSH guidelines for the standardization of bone marrow specimens and reports","volume":"30","author":"Lee","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197501000-00001","article-title":"The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature","volume":"54","author":"Chusid","year":"1975","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaci.2021.06.030_bib119","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood.V58.5.1012.1012","article-title":"A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations","volume":"58","author":"Flaum","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib120","first-page":"195","article-title":"Eosinophilic leukemia: a myeloproliferative disorder distinct from the hypereosinophilic syndrome","volume":"5","author":"Kueck","year":"1991","journal-title":"Hematol Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib121","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib122","first-page":"2","article-title":"Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome","volume":"95","author":"Bain","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib123","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3324\/haematol.2017.165340","article-title":"Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome","volume":"102","author":"Wang","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2021.06.030_bib124","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ajcp\/aqy064","article-title":"A test utilization approach to the diagnostic workup of isolated eosinophilia in otherwise morphologically unremarkable bone marrow: a single institutional experience","volume":"150","author":"Fang","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib125","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.06.030_bib126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11899-018-0469-3","article-title":"Clinical validation of KIT inhibition in advanced systemic mastocytosis","volume":"13","author":"Baird","year":"2018","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.jaci.2021.06.030_bib127","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2008-03-147785","article-title":"Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation","volume":"112","author":"Hoffmann","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A novel K509I mutation of KIT identified in familial mastocytosis-in\u00a0vitro and in\u00a0vivo responsiveness to imatinib therapy","volume":"30","author":"Zhang","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaci.2021.06.030_bib129","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1200\/JCO.2011.38.9973","article-title":"Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis","volume":"30","author":"Alvarez-Twose","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaci.2021.06.030_bib130","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1600-0609.2011.01598.x","article-title":"A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib","volume":"86","author":"Mital","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib131","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/ajh.25265","article-title":"Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases","volume":"93","author":"Shah","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib132","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/gcc.22526","article-title":"Incidence and prognostic impact of cytogenetic aberrations in patients with systemic mastocytosis","volume":"57","author":"Naumann","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.jaci.2021.06.030_bib133","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ajh.24553","article-title":"Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management","volume":"91","author":"Pardanani","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib134","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/leu.2015.284","article-title":"Additional mutations in SRSF2, ASXL1 and\/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2021.06.030_bib135","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/leu.2016.190","article-title":"Splenomegaly, elevated alkaline phosphatase and mutations in the SRSF2\/ASXL1\/RUNX1 gene panel are strong adverse prognostic markers in patients with systemic mastocytosis","volume":"30","author":"Jawhar","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2021.06.030_bib136","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/bjh.13865","article-title":"ASXL1 and CBL mutations are independently predictive of inferior survival in advanced systemic mastocytosis","volume":"175","author":"Pardanani","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib137","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/ajh.24880","article-title":"World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Gotlib","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib138","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1080\/10428194.2016.1197396","article-title":"The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes","volume":"58","author":"Maccaferri","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jaci.2021.06.030_bib139","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1038\/leu.2017.240","article-title":"Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia","volume":"31","author":"Jawhar","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2021.06.030_bib140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cancergen.2020.03.002","article-title":"Myeloid neoplasm with a novel cryptic PDGFRB rearrangement detected by next-generation sequencing","volume":"244","author":"Zimmermann","year":"2020","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jaci.2021.06.030_bib141","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1038\/leu.2014.168","article-title":"ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant","volume":"28","author":"Falchi","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2021.06.030_bib142","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/sj.leu.2404266","article-title":"FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation","volume":"20","author":"Vu","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.jaci.2021.06.030_bib143","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1182\/blood-2011-03-343426","article-title":"Response of ETV6-FLT3-positive myeloid\/lymphoid neoplasm with eosinophilia to inhibitors of FMS-like tyrosine kinase 3","volume":"118","author":"Walz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2021.06.030_bib144","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","article-title":"Characterization of leukemias with ETV6-ABL1 fusion","volume":"101","author":"Zaliova","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2021.06.030_bib145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00277-013-1843-9","article-title":"Successful allogeneic stem cell transplantation with long-term remission of ETV6\/FLT3-positive myeloid\/lymphoid neoplasm with eosinophilia","volume":"93","author":"Chonabayashi","year":"2014","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib146","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.exphem.2007.07.002","article-title":"A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapy","volume":"35","author":"Grand","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib147","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.2016.75","article-title":"Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified","volume":"29","author":"Wang","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jaci.2021.06.030_bib148","article-title":"Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2021.06.030_bib149","doi-asserted-by":"crossref","first-page":"40588","DOI":"10.18632\/oncotarget.5845","article-title":"Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome","volume":"6","author":"Andersen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaci.2021.06.030_bib150","first-page":"317","article-title":"Clonal hematopoiesis of indeterminate potential","volume":"113","author":"Heuser","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jaci.2021.06.030_bib151","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2007.05.024","article-title":"KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1\/PDGFRA-associated chronic eosinophilic leukemia are distinct entities","volume":"120","author":"Maric","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.06.030_bib152","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3816\/CLM.2006.n.029","article-title":"CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's macroglobulinemia and mast cell disorders","volume":"6","author":"Santos","year":"2006","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.jaci.2021.06.030_bib153","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.exphem.2006.09.008","article-title":"Effects of the CD33-targeted drug gemtuzumab ozogamicin (Mylotarg) on growth and mediator secretion in human mast cells and blood basophils","volume":"35","author":"Krauth","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jaci.2021.06.030_bib154","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1096\/fj.14-250894","article-title":"CD52 is a molecular target in advanced systemic mastocytosis","volume":"28","author":"Hoermann","year":"2014","journal-title":"FASEB J"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921010587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921010587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:32:47Z","timestamp":1758792767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921010587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":154,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0091674921010587"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.06.030","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A\u00a0Work Group Report of the AAAAI Allergic Skin Diseases Committee","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}